|Videos|August 26, 2021

Part 1: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML

Alexandra S. Wolff, PharmD, BCOP, discusses use of IDH1 and IDH2 inhibitors in newly diagnosed AML patients and highlights recently released trial data.


Latest CME